课题基金 / 基金详情

Advancement of antiviral inhibitors of chikungunya virus

Advancement of antiviral inhibitors of chikungunya virus
基孔肯雅病毒抗病毒抑制剂的研究进展
批准号:
10132230
负责人:
Daniel C Pevear
金额:
$100.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-13 至 2023-04-30

项目摘要

项目成果

Daniel C Pevear的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY Novel therapies for the treatment of chikungunya virus (CHIKV) infections are urgently needed to address the alarming spread of this pathogen across the Americas. We have identified three distinct series of potent, selective, and orally bioavailable inhibitors of CHIKV replication. In this Phase II renewal SBIR project, we will optimize these series of CHIKV inhibitors to Pre-Development stage and advance a first ever CHIKV antiviral candidate to IND-enabling studies. To accomplish this task, we will execute an integrated medicinal chemistry optimization/biological profiling campaign to optimize the potency, drug-like properties and oral exposure of each series. One or more Pre-Development Candidates will be identified and advanced through candidate selection studies into non-GLP repeat-dose tox in both rats and dogs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancement to Clinical Candidate of Novel, Potent and Selective Chikungunya virus inhibitor series
  • 批准号:
    9048725
  • 项目类别:
  • 资助金额:
    $113.91万
  • 财政年份:
    2016
  • 负责人:
    Daniel C Pevear
  • 依托单位:
Discovery and Advancement of Chikungunya virus inhibitors
  • 批准号:
    8905316
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2015
  • 负责人:
    Daniel C Pevear
  • 依托单位:
CCR5 inhibitors that block HIV but not chemokines
  • 批准号:
    6887677
  • 项目类别:
  • 资助金额:
    $31.36万
  • 财政年份:
    2004
  • 负责人:
    Daniel C Pevear
  • 依托单位:
Development of Small-Molecule HIV Entry Inhibitors
  • 批准号:
    6792155
  • 项目类别:
  • 资助金额:
    $87.43万
  • 财政年份:
    2001
  • 负责人:
    Daniel C Pevear
  • 依托单位:
海外基金